Capital Fund Management (CFM)
BNTX icon

Capital Fund Management (CFM)’s BioNTech BNTX Stock Holding History

Capital Fund Management (CFM)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,946
Closed -$1.71M – 2033
2024
Q3 		$1.78M Buy
+14,946
New +$1.37M ﹤0.01% 1495
2023
Q4 		– Sell
-18,035
Closed -$1.82M – 2110
2023
Q3 		$1.96M Buy
+18,035
New +$1.99M 0.01% 1372
2023
Q1 		– Sell
-13,785
Closed -$1.89M – 1560
2022
Q4 		$2.07M Sell
13,785
-19,644
-59% -$3.02M 0.01% 927
2022
Q3 		$4.51M Sell
33,429
-19,068
-36% -$2.92M 0.04% 578
2022
Q2 		$7.83M Sell
52,497
-1,492
-3% -$228K 0.07% 385
2022
Q1 		$9.21M Sell
53,989
-21,542
-29% -$3.62M 0.08% 359
2021
Q4 		$19.5M Buy
75,531
+19,564
+35% +$5.36M 0.14% 203
2021
Q3 		$15.3M Buy
55,967
+33,404
+148% +$10.6M 0.11% 243
2021
Q2 		$5.05M Buy
+22,563
New +$4.26M 0.04% 556

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital Fund Management (CFM)'s BNTX Position: Q4 2024 in Review

Capital Fund Management (CFM) sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 14,946 shares — an estimated $1.71M sold.

Capital Fund Management (CFM) first reported a position in BNTX in Q2 2021 and held it in 9 quarters. The position peaked at $19.5M in Q4 2021. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Capital Fund Management (CFM) reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 14,946 BioNTech shares in Q4 2024, an estimated $1.71M.
  • Capital Fund Management (CFM) first reported a position in BioNTech in Q2 2021 and held it in 9 quarters.
  • Capital Fund Management (CFM)'s BioNTech position peaked at $19.5M in Q4 2021.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2024, filed 13 Feb 2025.